Talling, Sitti Nurhata .

HRN: 23-33-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2024
AMPICILLIN 1GM (VIAL)
03/03/2024
03/03/2024
IV
2g
Q6hrs
PROM X 3 HOURS, GROSSLY LEAKING BOW
Waiting Final Action 
03/03/2024
CEFUROXIME 500MG (TAB)
03/03/2024
03/10/2024
PO
500
BID
2nd Degree EPISIOTOMY
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: